ROSA ANA
HERNÁNDEZ ANTOLÍN
Investigadora en el periodo 2009-2013
Erasmus University Medical Center
Róterdam, HolandaPublicaciones en colaboración con investigadores/as de Erasmus University Medical Center (7)
2018
-
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
The Lancet, Vol. 392, Núm. 10151, pp. 940-949
2014
-
Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: A pooled analysis of the EXAMINATION (clinical evaluation of the xience-V stent in acute myocardial INfArcTION) and COMFORTABLE-AMI
JACC: Cardiovascular Interventions, Vol. 7, Núm. 1, pp. 55-63
-
Optimization in stent implantation by manual thrombus aspiration in ST-segment-elevation myocardial infarction: Findings from the EXAMINATION trial
Circulation: Cardiovascular Interventions, Vol. 7, Núm. 3, pp. 294-300
2013
-
Everolimus-eluting stent versus bare metal stent in proximal left anterior descending ST-elevation myocardial infarction: Insights from the EXAMINATION trial
American Heart Journal, Vol. 166, Núm. 1
-
Predictors and clinical implications of stent thrombosis in patients with ST-segment elevation myocardial infarction: Insights from the EXAMINATION trial
International Journal of Cardiology, Vol. 168, Núm. 3, pp. 2632-2636
2012
-
Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial
The Lancet, Vol. 380, Núm. 9852, pp. 1482-1490
2011
-
Rationale and design of the EXAMINATION trial: A randomised comparison between everolimus-eluting stents and cobalt-chromium bare-metal stents in ST-elevation myocardial infarction
EuroIntervention, Vol. 7, Núm. 8, pp. 977-984